Jpmorgan Chase & CO HALOZYME THERAPEUTICS INC Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024
Number of Shares
6,047,000
Previous 5,560,000 8.76%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
N/A
487,000 Added 8.76%
6,047,000 $0
Q2 2024

Aug 12, 2024
SELL
N/A
-4,632,000 Reduced 45.45%
5,560,000 $0
Q1 2024

May 10, 2024
BUY
N/A
758,000 Added 8.03%
10,192,000 $0
Q4 2023

Feb 12, 2024
SELL
N/A
-1,935,000 Reduced 17.02%
9,434,000 $0
Q3 2023

Nov 14, 2023
SELL
N/A
-4,578,000 Reduced 28.71%
11,369,000 $0
Q2 2023

Aug 11, 2023
BUY
N/A
670,000 Added 4.39%
15,947,000 $0
Q1 2023

May 11, 2023
BUY
N/A
3,518,000 Added 29.92%
15,277,000 $0
Q4 2022

Feb 13, 2023
BUY
N/A
2,186,000 Added 22.84%
11,759,000 $11.4 Million
Q3 2022

Nov 14, 2022
BUY
N/A
893,000 Added 10.29%
9,573,000 $8.16 Million
Q1 2022

May 11, 2022
BUY
N/A
8,680,000 New
8,680,000 $7.67 Million
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email